Výsledky vyhledávání - David H. Gültekin
- Zobrazuji výsledky 1 - 6 z 6
-
1
Multiparametric Prostate MR Imaging with T2-weighted, Diffusion-weighted, and Dynamic Contrast-enhanced Sequences: Are All Pulse Sequences Necessary to Detect Locally Recurrent Pro... Autor Olivio F. Donati, Sung Il Jung, Hebert Alberto Vargas, David H. Gültekin, Junting Zheng, Chaya S. Moskowitz, Hedvig Hricak, Michael J. Zeléfsky, Oğuz Akın
Vydáno 2013Artigo -
2
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results Autor Oğuz Akın, David H. Gültekin, Hebert Alberto Vargas, Junting Zheng, Chaya S. Moskowitz, Xin Pei, Dahlia Sperling, Lawrence H. Schwartz, Hedvig Hricak, Michael J. Zeléfsky
Vydáno 2011Artigo -
3
Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results Autor Nancy E. Kemeny, Lawrence H. Schwartz, Mithat Gönen, Adam C. Yopp, David H. Gültekin, Michael I. D’Angelica, Yuman Fong, Dana Haviland, Alexandra N. Gewirtz, Peter J. Allen, William R. Jarnagin
Vydáno 2011Artigo -
4
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival Autor William R. Jarnagin, Lawrence H. Schwartz, David H. Gültekin, Mithat Gönen, Dana Haviland, Jinru Shia, M.I. D’Angelica, Yuman Fong, Ronald P. DeMatteo, Archie Tse, Leslie H. Blumgart, Nancy E. Kemeny
Vydáno 2009Artigo -
5
Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response Autor Adam C. Yopp, Lawrence H. Schwartz, Nancy E. Kemeny, David H. Gültekin, Mithat Gönen, Zubin M. Bamboat, Jinru Shia, Dana Haviland, Michael I. D’Angelica, Yuman Fong, Ronald P. DeMatteo, Peter J. Allen, William R. Jarnagin
Vydáno 2011Artigo -
6
Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors Autor A. Craig Lockhart, Mace L. Rothenberg, Jakob Dupont, Wendy Cooper, Paul Chevalier, Lars Sternås, Giliane Buzenet, Elizabeth Koehler, Jeffrey A. Sosman, Lawrence H. Schwartz, David H. Gültekin, Jason A. Koutcher, Edwin F. Donnelly, Ric Andal, Isabelle Dancy, David R. Spriggs, William P. Tew
Vydáno 2009Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Cancer
Chemotherapy
Radiology
Bevacizumab
Magnetic resonance imaging
Radiation therapy
Angiogenesis
Chemistry
Diffusion MRI
Dynamic contrast
Dynamic contrast-enhanced MRI
Gastroenterology
Nuclear medicine
Prostate cancer
VEGF receptors
Vascular endothelial growth factor
Aflibercept
Artificial intelligence
Biochemistry
Biomarker
Biopsy
Colorectal cancer
Computer science
Contrast (vision)
Dexamethasone
Effective diffusion coefficient
Environmental health
Floxuridine